Hot Pursuit     06-Dec-23
Indoco Remedies gains on USFDA nod for type 2 diabetes drug
Indoco Remedies rose 2.18% to Rs 393.50 after the company announced that it has received tentative approval from the USFDA for its abbreviated new drug application (ANDA) for canagliflozin tablets.
The said drug is generic equivalent of the reference listed drug, Invokana tablets of Janssen Pharmaceuticals, Inc. The product will be manufactured by Indoco Remedies, at their manufacturing facility located at Goa.

Canagliflozin tablets improve glycemic control in adults with type 2 diabetes mellitus.

Aditi Panandikar, managing director said, “Besides reflecting the capability of Indoco Remedies to deliver products of high-quality standards, this development also provides impetus to our growth aspirations in an important market such as the US.”

Indoco Remedies is engaged in the manufacturing and marketing of Formulations (finished dosage forms) and active pharmaceutical ingredients (APIs).

The company's consolidated net profit tumbled 33.24% to Rs 33.14 crore despite of 15% rise in net sales to Rs 465.24 crore in Q2 FY24 over Q2 FY23.

Previous News
  Warren Remedies commences commercial production of its greenfield units at Aurangabad
 ( Corporate News - 26-Mar-24   09:34 )
  Indoco Remedies consolidated net profit declines 14.70% in the December 2022 quarter
 ( Results - Announcements 24-Jan-23   12:32 )
  Indoco Remedies slumps after dismal Q3 performance
 ( Hot Pursuit - 24-Jan-23   12:37 )
  Indoco Remedies Ltd leads losers in 'B' group
 ( Hot Pursuit - 24-Jan-23   14:45 )
  Sensex down 224 pts; media shares decline
 ( Market Commentary - Mid-Session 09-Jun-23   14:32 )
  Indoco Remedies' Baddi unit receives EU GMP certification
 ( Corporate News - 09-Jun-23   14:34 )
  Indoco Remedies to convene AGM
 ( Corporate News - 31-Aug-23   14:05 )
  Board of Indoco Remedies recommends final dividend
 ( Corporate News - 25-May-21   16:01 )
  Indoco Remedies announces board meeting date
 ( Corporate News - 03-May-21   18:24 )
  Indoco Remedies to declare Quarterly Result
 ( Corporate News - 22-Apr-22   12:16 )
  Indoco Remedies consolidated net profit rises 228.43% in the September 2020 quarter
 ( Results - Announcements 06-Nov-20   14:40 )
Other Stories
  Dhanlaxmi Bank gains as gross advances rises 6% YoY in Q1 FY25
  05-Jul-24   15:27
  HDFC Bank Ltd leads losers in 'A' group
  05-Jul-24   15:00
  Shilpa Medicare sizzles after Unicycive gets positive results in clinical trials of OLC
  05-Jul-24   14:52
  Manugraph India Ltd leads losers in 'B' group
  05-Jul-24   14:45
  NSE SME Nephro Care India rallies on listing day
  05-Jul-24   14:45
  ESAF SFB total deposits jumps 33% YoY in Q1
  05-Jul-24   14:43
  Utkarsh SFB deposits climb 30% YoY in Q1 FY25
  05-Jul-24   14:35
  Volumes soar at Medplus Health Services Ltd counter
  05-Jul-24   14:30
  Financials stocks slide
  05-Jul-24   14:00
  Banking stocks edge lower
  05-Jul-24   14:00
Back Top